PT Medela Potentia Tbk

MDLA · JK · Healthcare / Medical Distribution

187.00IDR+5.00 (+2.75%)

Price History

Full chart

Market Stats

Previous Close182.00

Open182.00

Day Range182.00 – 190.00

52-Week Range175.00 – 281.65

Volume630.20K

Market Cap2.89T

P/E (TTM)7.00

Forward P/E0.00

EPS29.42

Dividend Yield6.12%

50-Day Avg208.12

200-Day Avg220.33

About

PT Medela Potentia Tbk distributes and markets pharmaceutical and healthcare products, and medical devices in Indonesia and Cambodia. It also manufactures medical devices, including consumables and medical equipment for hospitals and laboratories. The company also processes medical device products; and digital platform and web portal activities for human use, as well as pharmaceutical products. In addition, the company develops GoApotik, a B2B2C platform for expanding its products to retailers, end consumers, and patients. PT Medela Potentia Tbk was founded in 2011 and is headquartered in Jakarta Selatan, Indonesia.

Company Details

SectorHealthcare
IndustryMedical Distribution
CEOMs. . Juliwaty
Employees2.21K
HeadquartersJl. RS. Fatmawati Kav. 33, Jakarta Selatan, Indonesia, 12430, Indonesia
Websitehttps://www.medela-potentia.com

Leadership

Ms. . JuliwatyPresident Director
Mr. Tresno DhiwangkaraHead of the Internal Audit Unit
Mr. Wimala WidjajaCorporate Secretary & Director · b. 1955

Financials

Income Statement

Currency: IDR	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	11.60T	11.69T	13.09T	14.57T	14.89T
Growth (%)	-	+0.79%	+11.96%	+11.27%	+2.24%
Cost of Revenue	10.52T	10.59T	11.86T	13.21T	13.45T
Gross Profit	1.08T	1.10T	1.23T	1.36T	1.44T
Gross Margin	9.35%	9.44%	9.39%	9.34%	9.67%
Operating Expense	660.08B	698.04B	822.33B	894.77B	942.64B
Operating Income	424.53B	406.27B	407.59B	466.33B	496.82B
Operating Margin	3.66%	3.47%	3.11%	3.20%	3.34%
EBITDA	508.83B	496.73B	499.16B	500.63B	605.23B
EBITDA Margin	4.39%	4.25%	3.81%	3.44%	4.06%
Net Income	324.66B	311.83B	303.09B	345.03B	392.27B
Net Income Margin	2.80%	2.67%	2.32%	2.37%	2.63%
Interest Expense	11.64B	13.87B	10.61B	8.74B	12.04B
Interest Expense % of Total Revenue	0.10%	0.12%	0.08%	0.06%	0.08%

Balance Sheet

Currency: IDR	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	3.79T	4.42T	4.70T	5.73T	6.58T
Total Liabilities	2.06T	2.71T	2.75T	3.52T	3.48T
Total Equity	1.72T	1.64T	1.88T	2.14T	3.04T
Cash	768.53B	824.29B	253.17B	335.05B	694.16B
Total Debt	151.32B	376.41B	182.39B	231.37B	80.73B
Net Debt	-617.22B	-447.88B	-70.78B	-103.69B	-613.43B

Cash Flow

Currency: IDR	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	483.65B	287.64B	-166.77B	197.94B	521.55B
Investing Cash Flow	-53.45B	-129.73B	-76.47B	-76.62B	-478.75B
Financing Cash Flow	-55.31B	-103.77B	-327.31B	-40.41B	312.05B
Capital Expenditure	55.49B	52.94B	75.48B	47.37B	219.23B
Free Cash Flow	428.16B	234.71B	-242.25B	150.57B	302.33B
Dividends Paid	12.00B	364.00B	60.00B	115.00B	137.33B
FCF to OCF	88.53%	81.60%	145.26%	76.07%	57.97%
Dividend Paid to FCF	2.80%	155.09%	-24.77%	76.37%	45.42%

Key Statistics & Ratios

Market Cap2.89T

Enterprise Value2.43T

Trailing P/E7.00

Forward P/E0.00

Price / Sales0.18

Price / Book0.95

EPS29.42

Book Value219.44

Revenue (TTM)15.64T

Gross Profit (TTM)1.48T

EBITDA561.92B

Profit Margin2.65%

Operating Margin3.17%

Return on Equity14.98%

Return on Assets5.05%

Shares Outstanding14.01B

Shares Float2.45B

Dividend Yield6.12%

Dividend Rate12.60

Payout Ratio42.84%

Dividends

20261×

12.60May 25, 2026

20251×

9.80Jul 7, 2025